CraniUS LLC
$379.4K 1 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Elekta Instrument AB
Elekta Instrument AB reported $379,204.13 across General Payments, Research, and Ownership to 27 physicians and teaching hospitals across 29 transactions.
- $379.2K Above-median payer
- All-tracks total
- 29 Below-median volume
- Transactions
- 27 Below-median reach
- Recipients
- +$18.7K
- General Payments vs PY2023
Elekta Instrument AB reported $379,204.13 across all CMS Open Payments tracks (General + Research + Ownership) to 27 physicians and teaching hospitals in Program Year 2024 - ranking #840 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $354,204.13, averaging $14.0K per recipient.
How Elekta Instrument AB's $379.2K all-tracks total breaks down
Elekta Instrument AB's payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
18/100
Total payments
F
13/100
Transaction volume
F
10/100
Physician reach
F
10/100
Payment type diversity
F
37/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer elekta-instrument-ab Elekta Instrument AB
$379.2K · #840/1,925 · 0.0% industry · PY2024
- TOT $379.2K
- RANK #840
- SHARE 0.0%
- TXN 29
- RCP 27
- CAT 3
- GEN $354.2K
- ΔGEN +$18.7K
- TOP1 36.7%
- PY 2024
Volume peers
Nearest volume peer: CraniUS LLC ($379.4K)
Elekta Instrument AB sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Elekta Instrument AB's CMS-reported General Payments increased by $18.7K (+5.6%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: ELEKTA INSTRUMENT ABPY2023: ELEKTA INSTRUMENT ABPY2024: Elekta Instrument AB. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $335,550.00
- PY2024
- $354,204.13
What the Data Shows for Elekta Instrument AB
The all-tracks total above combines three CMS reporting categories - General Payments, Research Payments, and Ownership/Investment interests - not one undifferentiated figure. For Elekta Instrument AB, that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. CMS publishes each Program Year's data roughly 12 months after the reporting period ends, so this reflects the most recently released cycle; see our methodology for how the tracks are standardized and compared across companies.
Of the 3 general-payment categories charted below, "Consulting Fee" is the largest at $337.8K across 21 transactions, 95.4% of this company's General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
"Consulting Fee" leads Elekta Instrument AB's 3-category general-payment breakdown at $337.8K, 95.4% of the reported total.
How Elekta Instrument AB divides its payments
Ranked by total dollars reported per category
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Consulting Fee | $337.8K | 21 | 95.4% |
| Travel and Lodging | $15.5K | 3 | 4.4% |
| Food and Beverage | $844.73 | 3 | 0.2% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $348,114.40 (98.3%) of $354,204.13 in this company's General Payments records across 9 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Elekta Instrument AB
The five named recipients with the highest reported General Payments from this company
- 1
Upmc - Presbyterian Shadyside
$130,000.00 across 8 reported transactions
- 2
West Kendall Baptist Hospital
$113,500.00 across 4 reported transactions
- 3
Dheerendra Prasad
$62,114.40 across 7 reported transactions
- 4
Cleveland Clinic Hospital
$36,000.00 across 2 reported transactions
- 5
Arthur G James Cancer Hospital
$6,500.00 across 1 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Elekta Instrument AB's spend rank (#840 of 1,925, top 44% by spend) and concentration rank (#599 of 1,838, top 33% most concentrated) land at roughly the same percentile, an unusually proportionate case where payment size and payment concentration move together.
View all 12 companies in this HHI neighborhood as a list
- Analog Devices Inc. : $22.5K total payments, HHI 2816
- Promega Corporation : $17.3K total payments, HHI 2814
- Leadiant Biosciences, Inc. : $6.7K total payments, HHI 2813
- SRS Medical Systems, Inc. : $54.6K total payments, HHI 2811
- Wardlow Enterprises : $3.5K total payments, HHI 2803
- Stability Biologics, LLC : $235.6K total payments, HHI 2790
- Elekta Instrument AB (this company) : $354.2K total payments, HHI 2789
- Masimo Corporation : $2.6M total payments, HHI 2786
- Phadia AB : $11.9K total payments, HHI 2782
- Daiichi Sankyo Europe GmbH : $77.3K total payments, HHI 2769
- Pramand LLC : $22.8K total payments, HHI 2763
- Cleerly, Inc. : $157.5K total payments, HHI 2760
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Elekta Instrument AB's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Elekta Instrument AB.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Elekta Instrument AB.
Showing 6 of 1,924 companies with CMS-reported payment data.
Beaver-Visitec International, Inc.
$378.1K 100 recipients
Compare payment profiles
Flower Orthopedics Coporation
$381.4K 325 recipients
Compare payment profiles
Dentsply Ih Ab
$376.2K 886 recipients
Compare payment profiles
Helsinn Healthcare SA
$376.1K 40 recipients
Compare payment profiles
Boehringer Ingelheim Espana S.A.
$382.8K 2 recipients
Compare payment profiles
Put this to use
Elekta Instrument AB ranks #840 of 1,925 by all-tracks total payments, led by "Consulting Fee".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Consulting Fee" spend across every manufacturer, not just Elekta Instrument AB. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.